The surgical treatment of infective endocarditis: An overview

Indian Journal of Thoracic and Cardiovascular Surgery

Volumn 22, Issue 1, 2006, Pages 28-35

  Mestres, Carlos Alberto ^a   Miró, José Maria ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949368329     PISSN: 09709134     EISSN: 09737723     Source Type: Journal    
DOI: 10.1007/s12055-006-0504-1     Document Type: Review

References (88)

1. Osler W. Gulstonian lectures on malignant endocarditis. Lecture I. Lancet 1885; 1: 415-18.
2. Favaloro RG, En Casabé H, Suárez LD, Torino A (Eds.): Las formas actuales de la endocarditis infecciosa. Buenos Aires. Panamericana, 2000 pp IX.
3. Durack DT. Infective endocarditis. En Durack DT, Moellering Jr RC: Infective endocarditis. Infect Dis Clin N Am 2002; 16: XV-XIX.
4. 6 26 Barcelona. Ediciones Doyma. 2000. Depósito legal: B-20. 237.
5. Lewis T. Infective endocarditis. En: Diseases of the Heart. New York: Macmillan Company, 1933, 183-93.
6. Kay JH, Bernstein S, Feinstein D. Surgical cure of Candida albicans endocarditis with open-heart surgery. New Engl J Med 1961; 264: 907-10.
7. Wallace AG, Young WG, Osterhout S. Treatment of acute bacterial endocarditis by valve excision and replacement. Circulation 1965; 31: 450-53.
8. Von Reyn CF, Levy BS, Arbeit RD, Freidland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981; 94: 505-18.
9. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200-09.
10. Cabell CH, Abrutyn E. Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin N Am 2002; 16: 255-72.
11. Suárez LD. Endocarditis infecciosa ayer y hoy. En: Casabé H, Suárez LD, Torino A (Eds.) Las formas actuales de la endocarditis infecciosa. Buenos Aires. Panamericana, 2000, 1-5.
12. Fernández Guerrero ML. Epidemiología y microbiología de la endocarditis infecciosa. En Vilacosta I, Sarriá C, San Román JA (Eds.): Endocarditis infecciosa. Barcelona. Prous Science, 2002, 3-14.
13. Losa JE, Miró JM, Del Río A, Moreno-Camacho A, García F, Claramonte X, Marco F, Mestres CA, Azqueta M, Gatell JM and the Hospital Clínico Endocarditis Study Group. Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect 2003; 9: 45-54.
14. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954; 37: 171.
15. Kirklin JW, DuShane JW, Patrick RT, Donald DE, Hetzel PS, Harshbarger HG, Wood EH. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (Gibbon type): report of eight cases. Mayo Clin Proc 1955; 30: 201.
16. Akins CW. Results with mechanical cardiac valvular prostheses. Ann Thorac Surg 1995; 60: 1836-44.
17. Banbury MK, Cosgrove DM, Thomas JD, Blackstone EH, Rajeswaran J, Okies JE, Frater RWM. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2002; 73: 1460-1465.
18. Buckberg GD. Myocardial protection: entering the new millennium. J Card Surg 2002; 17: 447-50.
19. McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc 2000; 75: 1008-14.
20. Miró JM, Del Río A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin N Am 2002; 16: 273-95.
21. del Río A, Anguera I, Miró JM, Mont LL, Fowler VG, Azqueta M. Mestres CA and the Hospital Clínic Endocarditis Study Group. Surgical treatment of pacemaker and defibrillator-lead endocarditis. The impact of electrode lead extraction on outcome. Chest. 2003 (en prensa).
22. Karchmer AW, Longworth DL. Infection of intracardiac devices. Infect Dis Clin N Am 2002; 16: 477-05.
23. Wolff M, Witchitz S, Chastang C, Regnier B, Vachon F. Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest 1995; 108: 688-94.
24. Verheul HA, van den Brink RB, van Vreeland T, Moulijn AC, Duren DR, Dunning AJ. Effects of changes in management of active infective endocarditis on outcome in a 25-year period. Am J Cardiol 1993; 72: 682-87.
25. Casabé H, Suárez LD. Diagnóstico actual de la endocarditis infecciosa. En: Casabé H, Suárez LD, Torino A (Eds.). Las formas actuales de la endocarditis infecciosa. Buenos Aires, Panamericana, 2000, 119-27.
26. Delahaye F, Ecochard R, de Gevigney G, Barjhoux C, Malquarti V, Saradarian W, Delaye J. The long term prognosis of infective endocarditis. Eur Heart J 1995 Apr: 16 Suppl B: 48-53.
27. Jault F, Gandjbakhch I, Rama A, Nectoux M, Bors V, Vaissier E. Nataf P, Pavie A, Cabrol C: Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg 1997; 63: 1737-41.
28. Olaison L, Petterson G. Current best practices and guidelines. Indications for surgical intervention in infective endocarditis. Infect Dis Clin N Am 2002; 453-75.
29. Acar C. Cirugia en la endocarditis infecciosa. En: Vilacosta I, Sarriá C, San Román JA (Eds.): Endocarditis infecciosa. Barcelona, Prous Science, 2002, 317-22.
30. Bonow RO, Carabello B, de Leon AC, Edmonds LH Jr, Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA, O'Gara PT, O'Rourke RA, Rahimtoola SH, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Gibbons RJ, Russell RO, Ryan TJ, Smith SC Jr. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 1998; 7: 672-707.
31. Alsip CG, Blackstone EH, Kirklin JW, Cobbs CG. Indications for cardiac surgery in patients with active infective endocarditis. Am J Med 1985; 78 (Suppl 6B): 138-48.
32. Petterson G, Carbon C. The Endocarditis Working Group of the International Society of Chemotherapy. Recommendations for the surgical treatment of endocarditis. Clin Microbiol Infect 1998; 4: 34-36.
33. Bayer AS, Blomquist IK; Bello E, Chiu CY, Ward JI, Ginzton LE. Tricuspid valve endocarditis to Staphylococcus aureus correlation of two dimensional echocardiography with clinical outcome. Chest 1988; 93: 247-53.
34. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 1992; 117: 560-66.
35. Manolis AS, Melita H. Echocardiographic and clinical correlates in drug addicts with infective endocarditis. Implications of vegetations size. Arch Intern Med 1988; 148: 2461-65.
36. Anguera I, Quaglio G, Miro JM, Pare C, Azqueta M, Marco F, Mestres CA, Moreno A, Pomar JL, Mezzelani P, Sanz G. Aortocardiac fistulas complicating infective endocarditis. Am J Cardiol 2001; 87: 652-54.
37. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeter GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996; 112: 708-11.
38. Olaison L, Hogevik H, Myken P, Oden A, Alestig K. Q J Med 1996; 89: 267-78.
39. Alestig K, Hogevik H, Olaison L. Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium. Scand J Infect Dis 2000; 32: 343-56.
40. Casabé H, Hershon A, Ramos A. Estudio de endocarditis infecciosa en la República Argentina (EIRA). Complicaciones y mortalidad. Rev Argent Cardiol 1996; 6: 664-68.
41. Stutzbach P, Favaloro R. Tratamiento quirúrgico de la endocarditis infecciosa. En: Casabé H, Suárez LD, Torino A (Eds.): Las formas actuales de la endocarditis infecciosa. Buenos Aires. Panamericana, 2000, 145-63.
42. Jamieson WR, Edwards FH, Schwartz M, Bero JW, Clark RE, Grover FL. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Database Committee of The Society of Thoracic Surgeons. Ann Thorac Surg 1999; 67: 943-51.
43. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15: 816-22.
44. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-thorac Surg 1999; 16: 9-13.
45. Roques F, Nashef SA, Michel P, Pinna Pintor P, David M, Baudet E. The EuroSCORE Study Group. Does EuroSCORE work in individual European countries? Eur J Cardio-thorac Surg 2000; 18: 27-30.
46. Roques F, Nashef SA, Michel P, The EuroSCORE study group. Risk factors after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001; 10: 572-77.
47. Ross DN. Homograft replacement of the aortic valve. J Cardiovasc Surg (Torino) 1965; 18: Suppl: 89-94.
48. Barratt Boyes BG, Lowe JB, Cole DS, Kelly DT, Homograft valve replacement for aortic valve disease. Thorax 1965; 20: 495-04.
49. Yankah AC, Pasic M, Klose H, Siniawski H, Weng YG, Hetzer R. Homograft reconstruction of the aortic root for endocarditis with periannular abscess: A 17-year study. Eur J Cardiothorac Surg 2005; 28: 69-75.
50. Dossche K, Brutel de la Riviere A, Morshuis W, Schepens M, Ernst J. Aortic root replacement with human tissue valves in aortic valve endocarditis. Eur J Cardiothorac Surg 1997; 12: 47-55.
51. Mestres CA, Ninot S, Pomar JL. Complete translocation of the aortic root and coronary bypass grafting with a microporous polyurethane (Mitrathane) composite valved graft in the treatment of recurrent prosthetic valve endocarditis. Life Support Syst 1986; 4: 319-23.
52. Al-Attar N, Nottin R, Ramadan R, Azmoun A. Translocation of the aortic valve in severe aortic root abscess. An alternative to homografts. Eur J Cardio-thorac Surg 2005; 28: 509-10.
53. Sabik JF, Lythe BW, Blackstone EH, Marullo AG, Pettersson G, Cosgrove DM. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 2002; 74: 650-59.
54. Lytle BW, Sabik JF, blackstone EH, Svensson LG, Pettersson GB, Cosgrove DM. Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis. Ann Thorac Surg 2002; 74: S1754-57.
55. Glazier JJ, Verwilghen J, Donaldson RM, Ross DN. Treatment of complicated prosthetic aortic valve endocarditis by homograft aortic root replacement. J Am Coll Cardiol 1991; 17: 1177-82.
56. Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967; 2: 956-58.
57. Oswalt JD, Dewan SJ, Mueller MC. Nelson S. Highlights of a ten-year experience with the Ross procedure. Ann Thorac Surg 2001; 71 (5 Suppl): S332-35.
58. Banbury MK, Cosgrove DM 3rd, Thomas JD, Blackstone EH, Rajeswaran J, Okies JE, Frater RM. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2002; 73: 1460-65.
59. Guerra JM, Tornos MP, Permanyer-Miralda G, Almirante B, Murtra M, Soler-Soler J. Long term results of mechanical prostheses for treatment of active infective endocarditis. Heart 2001; 86: 63-8.
60. Engelberger L, Carrel T, Schaff HV, Kennard ED, Holubkov R, The advantage of repair of mitral valve in acute endocarditis. Differences in heart valve procedures between North American and European centers: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT). J Heart Valve Dis 2001; 10: 562-71.
61. Pansini S, di Summa M, Patane F, Forsennati PG, Serra M, Del Ponte S. Risk of recurrence after reoperation for prosthetic valve endocarditis. J Heart Val Dis 1997; 6: 84-87.
62. Ortu P, Mestres CA, Miró JM, Pomar JL. Staphylococcal postoperative subannular left ventricular false aneurysm. Eur J Cardiothorac Surg 2003; 23: 244-45.
63. Braunberger E, Deloche A, Berrebi A, Abdallah F, Celestin JA, Meimoun P, Chatellier G, Chauvaud S, Fabiani JN, Carpentier A. Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation 2001; 104: 18-11.
64. Tahta SA, Oury JH, Maxwell JM, Hiro SP, Duran CM. Outcome after mitral valve repair for functional ischemic mitral regurgitation. J Heart Valve Dis 2002; 11: 11-18.
65. Chauvaud S, Fuzellier JF, Berrebi A, Deloche A, Fabiani JN, Carpentier A. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation 2001; 104: 112-15.
66. Sternik L, Zehr KJ, Orszulak TA, Mullany CJ, Daly RC. Schaff HV. The advantage of repair of mitral valve in acute endocarditis. J Heart Valve Dis 2002; 11: 91-97.
67. Senni M, Merlo M, Sangiorgi G, Gamba A, Procopio A, Glauber M, Ferrazzi P. Mitral valve repair and transesophageal echocardiographic findings in a high risk subgroup of patients with active, acute infective endocarditis. J Heart Valve Dis 2001: 10: 72-77.
68. Ali M, Iung B, Lansac E, Bruneval P, Acar C. Homograft replacement of the mitral valve: eight-year results. J Thorac Cardiovasc Surg. 2004; 128: 529-34.
69. Mestres CA, Ginel A, Cartaná R, Pomar JL. Cryopreserved homografts in aortic and mitral prosthetic endocarditis: expanding the use of biological tisúes in complex cardiac infections. J Heart Valve Dis 1993; 2: 679-83.
70. Kabbani SS, Jamil H, Hammoud A, Hatab JA, Nabhani F, Hariri R, Sabbagh N, Ross DN. The mitral pulmonary autograft: assessment at midterm. Ann Thorac Surg 2004; 78: 60-65.
71. Fortún J, Navas E, Martínez-Beltrán J, Pérez-Molina J, Martín-Dávila P, Guerrero A, Moreno S. Short-course therapy fro rightsided endocarditis sue to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamycin. Clin Infect Dis 2001; 33: 120-25.
72. Arbulu A, Thoms NW, Wilson RF. Valvulectomy without prosthetic replacement. A lifesaving operation for tricuspid pseudomonas endocarditis. J Thorac Cardiovasc Surg 1972; 64: 103-07.
73. Arbulu A, Asfaw I. Tricuspid valvulectomy without prosthetic replacement. Ten years of clinical experience. J Thorac Cardiovasc Surg 1981; 82: 684-91.
74. Arbulu A, Holmes RJ, Asfaw I. Tricuspid valvulectomy without replacement. Twenty years' experience. J Thorac Cardiovasc Surg 1991; 102: 917-22.
75. Arbulu A, Holmes RJ, Asfaw I. Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience. U Heart Valve Dis 1993; 2: 129-37.
76. Lange R, De Simone R, Bauernschmitt R, Tanzeem A, Schmidt C, Hagl S. Tricuspid valve reconstruction, a treatment option in acute endocarditis. Eur J Cardiothorac Surg 1996; 10: 320-26.
77. Carozza A, Renzulli A, De Feo M, Ismeno G, Della Corte A, Dialetto G, Cotrufo M. Tricuspid repair for infective endocarditis: clinical and echocardiographic results. Tex Heart Inst J 2001; 28: 96-101.
78. Pomar JL, Mestres CA. Tricuspid valve replacement using a mitral homograft. Surgical technique and initial results. J Heart Valve Dis 1993; 2: 125-28.
79. Pomar JL, Mestres CA, Paré JC, Miró JM. Management of persistent tricuspid endocarditis with transplantation of cryopreserved mitral homografts. J Thorac Cardiovasc Surg 1994; 107: 1460-63.
80. Mestres CA, Miró JM, Parñe JC, Pomar JL. Six year experience with cryopreserved mitral homografts in the treatment of tricuspid valve endocarditis in HIV infected drug addicts. J Heart Valve Dis 1999; 8: 575-77.
81. Miyagishima RT, Brumwell ML, Jamieson WRF, Munt BI, Tricuspid valve replacement using a cryopreserved mitral homograft. Surgical technique and initial results. J Heart Valve Dis 2000; 9: 805-08.
82. Couetil JP, Argyriadis PG, Shafy A, Cohen A, Berrebi AJ, Loulmet DF, Chachques JC, Carpentier AF. Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis. Ann Thorac Surg 2002; 73: 1808-12.
83. Perez-Paredes M, Ramos Rincon JM, Carnero Varo A, Gimenez Cervantes DM, Blazquez Garrido R, Ruiz-Ros JA. Isolated pulmonary endocarditis on pative valve in elderly patient without predisposing factors. Rev Esp Cardiol 2001; 54: 402-04.
84. Valencia MF, Guine J, Soriano V. Estudio de 164 episodios de endocarditis infecciosa en drogadictos: comparación entre pacientes VIH positivos y negativos. Rev Clin Esp 1994; 194: 535-39.
85. Manoff SB, Vlahov D, Herskowitz A, Solomon L, Muñoz A, Cohn S, Willoughby SB, Nelson KE. Human immunodeficiency virus infection and infective endocarditis among injecting drug addicts. Epidemiology 1996; 7: 563-65.
86. Aris A, Pomar JL, Saura E. Cardiopulmonary bypass in HIV positive patients. Ann Thorac Surg 1993; 55: 1104-08.
87. Mestres CA, Chuquiure J, Claramonte X, Muñoz J, Benito N, Castro MA, Pomar JL, Miró JM and The Hospital Clinic Endocarditis Study Group. Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1). Eur J Cardiothorac Surg 2003; 23: 1007-16.
88. Aberegg SK. Cardiac transplantation in an HIV-1-infected patient. N Engl J Med. 2003; 349: 1388-89.